Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD
Solène M. Laville(Centre Hospitalier Universitaire Amiens-Picardie), Hacène Sekhri, Christian Combe(Université de Bordeaux), Denis Fouque(Université Claude Bernard Lyon 1), Bruno Moulin(Université de Strasbourg), Éric Magnant, Thierry Lobbedez, Thierry Hannedouche, Bruce Robinson(University of Michigan), Marie Metzger, Sébastien Mailliez, Carole Ayav(Inserm), Sophie Liabeuf(Centre Hospitalier Universitaire Amiens-Picardie), Christian Jacquelinet(Université Paris-Sud), Dorothée Cannet, Gaëtan Lebrun(Assistance Publique – Hôpitaux de Paris), Julien Moragny(Centre Hospitalier Universitaire Amiens-Picardie), Oriane Lambert(Inserm), Valérie Gras‐Champel(Centre Hospitalier Universitaire Amiens-Picardie), Gabriel Choukroun(Centre Hospitalier Universitaire Amiens-Picardie), Benjamin Deroure, Bénédicte Stengel(Inserm), Ziad A. Massy(Inserm), Élodie Speyer, Adeline Lacraz(Centre Hospitalier Universitaire de Bordeaux), Luc Frimat(Centre Hospitalier Régional et Universitaire de Nancy), Aghilès Hamroun(Université de Lille), Marie Essig, Natália Alencar de Pinho(Inserm), Raymond Azar, Maurice Laville(Lyon 1 Université), Serge Briançon, Bourdenx, Céline Lange, Christophe Pascal, G Lambrey, Sophie Liabeuf(Centre Hospitalier Universitaire Amiens-Picardie), Maurice Laville(Lyon 1 Université), Jean Philippe(Aix-Marseille Université), Yves-Édouard Herpe, Karine Legrand, Brian Bieber(Arbor Research Collaborative for Health)
Cited by 34
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766